# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.

# Submitter name, address, contact

Roche Diagnostics Corporation   
9115 Hague Road   
Indianapolis, IN 46250   
(317) 521-3338

Contact Person: Jane Phillips

Date Prepared: 07/09/2009

# Device Name

roprietary name:1.Elecsys Troponin I Immunoassay Elecsys® Troponin I STAT Immunoassay Elecsys®PreciControl Troponin Elecsys Troponin I CalSet

Common name: Troponin I Immunoassay .Troponin I STAT Immunoassay PreciControl Troponin Troponin I CalSet Troponin I STAT CalSet

Classification name: 1.) Immunoassay Method, Troponin Subunit Immunoassay Method, Troponin Subunit Multi-Analyte Controls, All Kinds (assayed) Calibrator, Secondary Calibrator, Secondary

# Description

1.) The Elecsys Troponin I immunoassay is a two step sandwich immunoassay with streptavidin microparticles and electrochemiluminescence detection. Results are determined using a calibration curve that is generated specifically on each instrument by a 2 point calibration and a master curve provided with the reagent bar code.   
The Elecsys Troponin I STAT immunoassay is a two step sandwich immunoassay with streptavidin microparticles and electrochemiluminescence detection. Results are determined using a calibration curve that is generated specifically on each instrument by a 2 point calibration and a master curve provided with the reagent bar code.   
The Elecsys PreciControl Troponin is a lyophilized product consisting of human serum with added Troponin T and Troponin I in two concentration ranges. During manufacture, the analytes are spiked into the matrix at the desired concentration levels.   
4.) The Elecsys Troponin I CalSet is a lyophilized product consisting of human serum with added Troponin I in two concentration ranges. During manufacture, the analyte is spiked into the matrix at the desired concentration levels.   
5.) The Elecsys Troponin I STAT CalSet is a lyophilized product consisting of human serum with added Troponin I in two concentration ranges. During manufacture, the analyte is spiked into the matrix at the desired concentration levels.

Note: The reagent, calibrator, and quality control materials are all packaged separately.

Elecsys Troponin I Immunoassay: Immunoassay for the in vitro quantitative determination of cardiac troponin I in human serum and plasma. The Elecsys Troponin I assay is intended to aid in the diagnosis of myocardial infarction.

The electrochemiluminescence immunoassay "ECLIA" is intended for use on the Elecsys and MODULAR Analytics E170 immunoassay analyzers.

Elecsys Troponin I STAT Immunoassay: Immunoassay for the in vitro quantitative determination of cardiac troponin I in human serum and plasma. The Elecsys Troponin I STAT assay is intended to aid in the diagnosis of myocardial infarction.

The electrochemiluminescence immunoassay "ECLIA" is intended for use on the Elecsys analyzers.

Elecsys PreciControl Troponin is used for quality control of the Elecsys Troponin I and Elecsys Troponin I STAT immunoassays on the Elecsys and MODULAR Analytics E170 Analyzers.

The Elecsys Troponin I CalSet is used for calibrating the quantitative Elecsys Troponin I assay on the Elecsys and MODULAR Analytics E170 analyzers.

The Elecsys Troponin I STAT CalSet is used for calibrating the quantitative Elecsys Troponin I STAT assay on the Elecsys analyzers.

Substantial equivalence

The Elecsys Troponin I and Troponin I STAT Test Systems are substantially equivalent to other devices legally marketed in the United States.

1.). Elecsys Troponin I and Troponin I STAT Immunoassays are equivalent to the Beckman Coulter Access AccuTnI Immunoassay (K021814).   
Elecsys PreciControl Troponin is equivalent to Elecsys PreciControl Cardiac II (K072437).   
3 Elecsys Troponin I CalSet and Troponin I STAT CalSet are equivalent to Elecsys proBNP II CalSet (K072437).

# 510(k) Summary, continued

# Device ComparisonImmunoassay

The following table compares the Elecsys Troponin I STAT test system with the predicate device (K021814).

Substantial equivalence - comparison to the predicate device   

<table><tr><td rowspan=1 colspan=3>Immumoassay</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys Troponin I STAT Assay</td><td rowspan=1 colspan=1>Beckman Coulter AccessAccuTnI(K021814) Predicate</td></tr><tr><td rowspan=1 colspan=1>Intended Use /Indication for Use</td><td rowspan=1 colspan=1>Immunoassay for the in vitroquantitative determination ofcardiac troponin l in human serumand plasma. The Elecsys TroponinI STAT assay is intended to aid inthe diagnosis of myocardialinfarction.The electrochemiluminescenceimmunoassay &quot;ECLIA&quot; is intendedfor use on the Elecsys analyzers.</td><td rowspan=1 colspan=1>The Access AccuTnI assay is aparamagnetic particle,chemiluminescent immunoassayfor the quantitative determinationof cardiac troponin I (cTnI) levelsin human serum and plasma usingthe Access Immunoassay Systemsto aid in the diagnosis andtreatment of myocardial infarctionand cardiac muscle damage.Cardiac troponin I determinationaids in the risk stratification ofpatients with unstable angina ornon-ST segment elevation acutecoronary syndromes with respect torelative risk of mortality,myocardial infarction, or increasedprobability of ischemic eventsrequiring urgent revascularizationprocedures.</td></tr><tr><td rowspan=1 colspan=1>Assay Protocol</td><td rowspan=1 colspan=1>Sandwich Principle</td><td rowspan=1 colspan=1>Sandwich Principle</td></tr><tr><td rowspan=1 colspan=1>Detection Protocol</td><td rowspan=1 colspan=1>Electrochemiluminescence</td><td rowspan=1 colspan=1>Chemiluminescence</td></tr></table>

# 510(k) Summary, continued

<table><tr><td rowspan=1 colspan=3>Immunoassay, continued</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys Troponin I STAT Assay</td><td rowspan=1 colspan=1>Beckman Coulter AccessAccuTnI(K021814) Predicate</td></tr><tr><td rowspan=1 colspan=1>Traceability /Standardization</td><td rowspan=1 colspan=1>Standardized against the BeckmanCoulter Access AccuTnI assay.</td><td rowspan=1 colspan=1>Not stated.</td></tr><tr><td rowspan=1 colspan=1>Calibration Interval</td><td rowspan=1 colspan=1>Calibration must be performedonce per reagent lot using freshreagent. Renewed calibration:After 1 month (28 days)when using the samereagent lotAfter 7 days (when usingthe same reagent kit on theanalyzer)</td><td rowspan=1 colspan=1>An active calibration curve isrequired for all tests. For theAccess AccuTnI assay, calibrationis required every 56 days.</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Human serum and plasma</td><td rowspan=1 colspan=1>Human serum and plasma</td></tr><tr><td rowspan=1 colspan=1>Reagent Stability</td><td rowspan=1 colspan=1>UnopenedUp to stated expiration datestored at 2-8°CAfter Opening4 weeks at 2-8°2 weeks on the analyzers</td><td rowspan=1 colspan=1>Unopened•  Up to stated expiration datestored at 2-8°CAfter Opening.  Stable at 2 - 10°C for 56days after initial use</td></tr><tr><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Elecsys Troponin I STAT CalSet</td><td rowspan=1 colspan=1>Access AccuTnI Calibrators</td></tr><tr><td rowspan=1 colspan=1>Controls</td><td rowspan=1 colspan=1>Elecsys PreciControl Troponin</td><td rowspan=1 colspan=1>Commercial control material</td></tr><tr><td rowspan=1 colspan=1>Expected values</td><td rowspan=1 colspan=1>Age 20 - 79, expected value &lt; 0.3ng/mL:Values less than O.3 ng/mL will bereported as &quot;&lt; 0.3 ng/mL.&quot;.</td><td rowspan=1 colspan=1>Age 19- 88:97.5thpercentile: 0.03 ng/mL99thpercentile: 0.04 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Instrument</td><td rowspan=1 colspan=1>Elecsys Analyzers</td><td rowspan=1 colspan=1>Access Immunoassay Systems</td></tr><tr><td rowspan=1 colspan=1>Measuring Range</td><td rowspan=1 colspan=1>0.30 -25.00 μg/L (ng/mL)</td><td rowspan=1 colspan=1>0.01 − 100.00 μg/L (ng/mL)</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys Troponin ISTAT Assay</td><td rowspan=1 colspan=1>Elecsys Troponin ISTAT Assay</td><td rowspan=1 colspan=1>Beckman CoulterAccess AccuTnI(K021814) Predicate</td></tr><tr><td rowspan=2 colspan=1>Precision</td><td rowspan=1 colspan=1>US Site 1Repeatability (within-run)</td><td rowspan=2 colspan=1>EU Site 1Repeatability2.5% CV @ 0.447ng/mL4.1% CV @ 0.347ng/mL0.7% CV @ 7.600ng/mL3.1% CV @ 0.498ng/mL2.6% CV @ 0.395ng/mL0.6% CV @ 17.600ng/mLIntermediate Precision6.1% CV @ 0.447ng/mL8.0% CV @ 0.347ng/mL4.3% CV @ 7.600ng/mL5.4% CV @ 0.498ng/mL4.8% CV @ 0.395ng/mL1.9% CV @ 17.600ng/mL</td><td rowspan=2 colspan=1>Within Run:4.03% CV @ 0.56 ng/mL3.06% CV @ 7.31 ng/mL3.29% CV @ 30.55ng/mL4.42% CV @ 0.42 ng/mL3.42% CV @ 1.34 ng/mLBetween Run:2.97% CV @ 0.56 ng/mL4.12% CV @ 7.31 ng/mL6.07% CV @ 30.55ng/mL2.71% CV @ 0.42 ng/mL2.75% CV @ 1.34 ng/mLTotal Imprecision:5.01% CV @ 0.56 ng/mL5.13% CV @ 7.31 ng/mL6.90% CV @ 30.55ng/mL5.19% CV @ 0.42 ng/mL4.39% CV @ 1.34 ng/mL</td></tr><tr><td rowspan=1 colspan=1>4.8% CV @ 0.323 ng/mL3.3% CV @ 0.496 ng/mL2.2% CV @ 0.627 ng/mL1.7% CV @ 21.400 ng/mL4.2% CV @ 0.439 ng/mL2.9% CV @ 17.800 ng/mLIntermediate Precision(betwcen-run andbetween-day)8.9% CV @ 0.323 ng/mL5.9% CV @ 0.496 ng/mL5.3% CV @ 0.627 ng/mL3.2% CV @ 21.400 ng/mL6.7% CV @ 0.439 ng/mL3.6% CV @ 17.800 ng/mLUS Site 2Repeatability3.0% CV @ 0.483 ng/mL3.9% CV @ 0.329 ng/mL1.8% CV @ 2.180 ng/mL2.1% CV @ 0.691 ng/mL4.0% CV @ 0.376 ng/mL2.3% CV @ 17.300 ng/mLIntermediate Precision4.0% CV @ 0.483 ng/mL5.7% CV @ 0.329 ng/mL2.4% CV @ 2.180 ng/mL2.9% CV @ 0.691 ng/mL5.3% CV @ 0.376 ng/mL2.6% CV @ 17.300 ng/mL</td></tr></table>

# 510(k) Summary, continued

<table><tr><td colspan="3" rowspan="1">mmunoassay.continued</td></tr><tr><td colspan="1" rowspan="1">Feature</td><td colspan="1" rowspan="1">Elecsys Troponin I STAT Assay</td><td colspan="1" rowspan="1">Beckman Coulter AccessAccuTnI(K021814) Predicate</td></tr><tr><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">0.3 ng/mL</td><td colspan="1" rowspan="1">0.5 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Hook Effect</td><td colspan="1" rowspan="1">1,000 ng/mL</td><td colspan="1" rowspan="1">1,920 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Method Comparison</td><td colspan="1" rowspan="1">N= 114Range = 0.35 - 21.54 ng/mLPassing/Bablok:y = 0.7954x + 0.2187tau = 0.8058Linear Regression:y = 0.7878x + 0.3204r = 0.9519Demingy = 0.8198x + 0.2168 =0.9465</td><td colspan="1" rowspan="1">N = 157Range = 0.03 - 44.89Intercept = -1.039 ng/mLSlope = 0.932r = 0.980</td></tr><tr><td colspan="1" rowspan="1">Limit of Blank</td><td colspan="1" rowspan="1">Studies done and LoB is less thanLoQ (0.3 ng/mL)</td><td colspan="1" rowspan="1">Not given</td></tr><tr><td colspan="1" rowspan="1">Limit of Detection /Analytical Sensitivity</td><td colspan="1" rowspan="1">Studies done and LoB is less thanLoQ (0.3 ng/mL)</td><td colspan="1" rowspan="1">= 0.01 ng/mL (LDL)</td></tr><tr><td colspan="1" rowspan="1">Limit of Quantitation /Functional Sensitivity</td><td colspan="1" rowspan="1">= 0.3 ng/mL at 10% CV</td><td colspan="1" rowspan="1">= 0.03 ng/mL at 20% CV= 0.06 ng/mL at 10% CV</td></tr><tr><td colspan="2" rowspan="1">Immunoassay, continued</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Feature</td><td colspan="1" rowspan="1">Elecsys Troponin 1 STAT Assay</td><td colspan="1" rowspan="1">Beckman Coulter AccessAccuTnI(K021814) Predicate</td></tr><tr><td colspan="1" rowspan="1">Limitations</td><td colspan="1" rowspan="1">No interference from bilirubinif less than 25 mg/dLNo interference fromhemoglobin if less than 400mg/dLNo interference from Intralipidif less than 1500 mg/dLNo interference from biotin ifless than 30 ng/mLNo interference fromrheumatoid factor up to 1500IU/mLIn patients receiving high biotindoses &gt; 5 mg/day, sampleshould not be taken until 8hours after administration.Rare occurrence of interferencefrom high titers of anti-streptavidin and rutheniumUse in conjunction with patientmedical history, clinical examand other findings</td><td colspan="1" rowspan="1">No interference from bilirubinup to 40 mg/dLNo interference from fibrinogenup to 1000 mg/dLNo interference fromtriglycerides up to 1000 mg/dLNo interference fromhemoglobin up to 500 mg/dLNo interference from humanserum albumin up to 6000mg/dL</td></tr></table>

# 510(k) Summary, continued

Device   
Comparison  
Control

The following table compares the Elecsys Troponin I Assay (18 Minute) with the predicate device (K021814).

# Substantial equivalence - comparison to the predicate device

<table><tr><td rowspan=1 colspan=3>mmunoassay</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys Troponin I Assay</td><td rowspan=1 colspan=1>Beckman Coulter AccessAccuTnI(K021814) Predicate</td></tr><tr><td rowspan=1 colspan=1>Intended Use /Indication for Use</td><td rowspan=1 colspan=1>Immunoassay for the in vitroquantitative determination ofcardiac troponin I in human serumand plasma. The Elecsys TroponinI assay is intended to aid in thediagnosis of myocardial infarction.The electrochemiluminescenceimmunoassay &quot;ECLIA&quot; is intendedfor use on the Elecsys andMODULAR Analytics E170immunoassay analyzers.</td><td rowspan=1 colspan=1>The Access AccuTnI assay is aparamagnetic particle,chemiluminescent immunoassayfor the quantitative determinationof cardiac troponin I (cTnI) levelsin human serum and plasma usingthe Access Immunoassay Systemsto aid in the diagnosis andtreatment of myocardial infarctionand cardiac muscle damage.Cardiac troponin I determinationaids in the risk stratification ofpatients with unstable angina ornon-ST segment elevation acutecoronary syndromes with respect torelative risk of mortality,myocardial infarction, or increasedprobability of ischemic eventsrequiring urgent revascularizationprocedures.</td></tr><tr><td rowspan=1 colspan=1>Assay Protocol</td><td rowspan=1 colspan=1>Sandwich Principle</td><td rowspan=1 colspan=1>Sandwich Principle</td></tr><tr><td rowspan=1 colspan=1>Detection Protocol</td><td rowspan=1 colspan=1>Electrochemiluminescence</td><td rowspan=1 colspan=1>Chemiluminescence</td></tr></table>

<table><tr><td colspan="3" rowspan="1">unoassay contiuet</td></tr><tr><td colspan="1" rowspan="1">Feature</td><td colspan="1" rowspan="1">Elecsys Troponin I Assay</td><td colspan="1" rowspan="1">Beckman Coulter AccessAccuTnI(K021814) Predicate</td></tr><tr><td colspan="1" rowspan="1">Traceability /Standardization</td><td colspan="1" rowspan="1">Standardized against the BeckmanCoulter Access AccuTnl assay.</td><td colspan="1" rowspan="1">Not stated.</td></tr><tr><td colspan="1" rowspan="1">Calibration Interval</td><td colspan="1" rowspan="1">Calibration must be performedonce per reagent lot using freshreagent. Renewed calibration:After 1 month (28 days)•when using the samereagent lot9   After 7 days (when usingthe same reagent kit on theanalyzer)</td><td colspan="1" rowspan="1">An active calibration curve isrequired for all tests: For theAccess AccuTnI assay, calibrationis required every 56 days.</td></tr><tr><td colspan="1" rowspan="1">Sample Type</td><td colspan="1" rowspan="1">Human serum and plasma</td><td colspan="1" rowspan="1">Human serum and plasma</td></tr><tr><td colspan="1" rowspan="1">Reagent Stability</td><td colspan="1" rowspan="1">Unopened0   Up to stated expiration datestored at 2-8°After Opening4 weeks at 2-8°C2 weeks on the analyzers</td><td colspan="1" rowspan="1">UnopenedUp to stated expiration datestored at 2-8°After Opening.  Stable at 2 - 10°C for 56days after initial use</td></tr><tr><td colspan="1" rowspan="1">Calibrator</td><td colspan="1" rowspan="1">Elecsys Troponin I CalSet</td><td colspan="1" rowspan="1">Access AccuTnI Calibrators</td></tr><tr><td colspan="1" rowspan="1">Controls</td><td colspan="1" rowspan="1">Elecsys PreciControl Troponin</td><td colspan="1" rowspan="1">Commercial control material</td></tr><tr><td colspan="1" rowspan="1">Expected values</td><td colspan="1" rowspan="1">Age 20 - 79 expected value &lt; 0.3ng/mL:Values less than 0.3 ng/mL will bereported as "&lt; 0.3 ng/mL".</td><td colspan="1" rowspan="1">Age 19 - 88:97.5h percentile: 0.03 ng/mL99th percentile: 0.04 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">Elecsys and MODULAR AnalyticsE170 Analyzers</td><td colspan="1" rowspan="1">Access Immunoassay Systems</td></tr><tr><td colspan="1" rowspan="1">Measuring Range</td><td colspan="1" rowspan="1">0.30 - 25.00 µg/L (ng/mL)</td><td colspan="1" rowspan="1">0.01 - 100 μg/L (ng/mL)</td></tr><tr><td colspan="1" rowspan="1">Feature</td><td colspan="1" rowspan="1">Elecsys Troponin I Assay</td><td colspan="1" rowspan="1">Beckman Coulter AccessAccuTnI(K021814) Predicate</td></tr><tr><td colspan="1" rowspan="2">Precision</td><td colspan="1" rowspan="1">Repeatability (within run)5.3% CV @ 0.322 ng/mL5.2% CV @ 0.425 ng/mL2.7% CV @ 17.6 ng/mL7.0% CV @ 0.340 ng/mL2.6% CV @ 18.0 ng/mLIntermediate Precision (between-run and</td><td colspan="1" rowspan="2">Within Run:4.03% CV @ 0.56 ng/mL3.06% CV @ 7.31 ng/mL3.29% CV @ 30.55 ng/mL4.42% CV @ 0.42 ng/mL3.42% CV @ 1.34 ng/mLBetween Run:2.97% CV @ 0.56 ng/mL4.12% CV @ 7.31 ng/mL6.07% CV @ 30.55 ng/mL2.71% CV @ 0.42 ng/mL2.75% CV @ 1.34 ng/mLTotal Imprecision:5.01% CV @ 0.56 ng/mL5.13% CV @ 7.31 ng/mL6.90% CV @ 30.55 ng/mL5.19% CV @ 0.42 ng/mL4.39% CV @ 1.34 ng/mL</td></tr><tr><td colspan="1" rowspan="1">between-day)8.7% CV @ 0.322 ng/mL7.3% CV @ 0.425 ng/mL4.7% CV @ 17.6 ng/mL8.0% CV @ 0.340 ng/mL4.4% CV @ 18.0 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">0.3 ng/mL</td><td colspan="1" rowspan="1">0.5 ng/mL</td></tr></table>

Iumumoassay. continued   

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys Troponin I Assay</td><td rowspan=1 colspan=1>Beckman Coulter AccessAccuTnI(K021814) Predicate</td></tr><tr><td rowspan=1 colspan=1>Hook Effect</td><td rowspan=1 colspan=1>1000 ng/mL</td><td rowspan=1 colspan=1>1,920 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Method Comparison</td><td rowspan=1 colspan=1>N= 115Range = 0.34 - 24.62 ng/mLPassing/Bablok:y = 0.9743x - 0.00172tau = 0.9616Linear Regression:y = 0.9934x - 0.0623r = 0.9934Deming Regressiony = 1x - 0.1080r = 0.9971</td><td rowspan=1 colspan=1>N = 157Range = 0.03 - 44.89Intercept = -1.039 ng/mLSlope = 0.932r =0.980</td></tr><tr><td rowspan=1 colspan=1>Limit of Blank</td><td rowspan=1 colspan=1>Studies done and LoB is less thanLoQ (0.3 ng/mL)</td><td rowspan=1 colspan=1>Not given</td></tr><tr><td rowspan=1 colspan=1>Limit of Detection /Analytical Sensitivity</td><td rowspan=1 colspan=1>Studies done and LoD is less thanLoQ (0.3 ng/mL)</td><td rowspan=1 colspan=1>0.01 ng/mL (LDL)</td></tr><tr><td rowspan=1 colspan=1>Limit of Quantitation /Functional Sensitivity</td><td rowspan=1 colspan=1>= 0.3 ng/mL at 10% CV</td><td rowspan=1 colspan=1>0.03 ng/mL at 20% CV0.06 ng/mL at 10% CV</td></tr></table>

Immunoassay, continued   

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys Troponin I Assay</td><td rowspan=1 colspan=1>Beckman Coulter AccessAccuTnI(K021814) Predicate</td></tr><tr><td rowspan=1 colspan=1>Limitations</td><td rowspan=1 colspan=1>No interference from bilirubinif less than 25 mg/dLNo interference fromhemoglobin if less than 400mg/dLNo interference from Intralipidif less than 1500 mg/dLNo interference from biotin ifless than 30 ng/mLNo interference fromrheumatoid factor up to 1500IU/mLIn patients receiving high biotindoses &gt; 5 mg/day, sampleshould not be taken until 8hours after administration.Rare occurrence of interferencefrom high titers of anti-streptavidin and rutheniumUse in conjunction with patientmedical history, clinical examand other findings</td><td rowspan=1 colspan=1>No interference from bilirubinup to 40 mg/dLNo interference from fibrinogenup to 1000 mg/dLNo interference fromtriglycerides up to 1000 mg/dLNo interference fromhemoglobin up to 500 mg/dLNo interference from humanserum albumin up to 6000mg/dL</td></tr></table>

$$
\cdot
$$

The following table compares the Elecsys PreciControl Troponin with the predicate device (K072437).

Device Comparison - Control   

<table><tr><td rowspan=1 colspan=3>PreciControl Comparison</td></tr><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecsys PreciControl Troponin I</td><td rowspan=1 colspan=1>Elecsys PreciControl Cardiac II(K072437) Predicate</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Used for quality control of theElecsys Troponin I and ElecsysTroponin I STAT immunoassayson the Elecsys and MODULARAnalytics E170 Analyzers.</td><td rowspan=1 colspan=1>Used for quality control ofspecified immunoassays on theElecsys and cobas e immunoassayanalyzers.</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Two</td><td rowspan=1 colspan=1>Two</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized, human serum</td><td rowspan=1 colspan=1>Lyophilized, human serum</td></tr><tr><td rowspan=1 colspan=1>Analyte Concentration</td><td rowspan=1 colspan=1>Troponin T: approx. 0.03 ng/mLand 2.5 ng/mLTroponin I: 0.4 ng/mL and 18ng/mL</td><td rowspan=1 colspan=1>CK-MB: approx. 5 and 50 ng/mlDigitoxin: approx 17 and 38ng/mL (not for use in U.S.)Digoxin: approx. 1.2 and 3 ng/mlMyoglobin: approx. 80 and 1000ng/mlNT-proBNP: approx. 0.15 and 5ng/ml</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened: store at 2 - 8°C up toexpiration dateReconstituted:5 hrs at 20 - 25°C (on analyzer)4 days at 2 - 8°C3 months at -20°C (freeze onlyonceAfter thawing - use only once</td><td rowspan=1 colspan=1>Unopened: store at 2 - 8°C up toexpiration dateReconstituted:3 hrs at 20 - 25°C (on analyzer)3 days at 2 - 8°C3 months at -20°C (freeze onlyonce)After thawing - use only once</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Dissolve carefully the contents ofone bottle by adding exactly 2.0mL of distilled water and allowstand closed for 60 minutes toreconstitute. Mix carefully,avoiding the formation of foam.</td><td rowspan=1 colspan=1>Dissolve carefully the contents ofone bottle by adding exactly 2.0mL of distilled water and allowstand closed for 15 minutes toreconstitute. Mix carefully,avoiding the formation of foam.</td></tr></table>

The following table compares the Elecsys Troponin I CalSet with the predicate device (K072437).

Device ComparisonCalSet   

<table><tr><td rowspan=1 colspan=3>CalSet Comparison</td></tr><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecsys Troponin I CalSet</td><td rowspan=1 colspan=1>Elecsys proBNP II CalSet(K072437) Predicate</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The Elecsys Troponin I CalSet isused for calibrating the quantitativeElecsys Troponin I assay on theElecsys and MODULAR AnalyticsE170 analyzers.</td><td rowspan=1 colspan=1>Used for calibrating thequantitative Elecsys proBNP IIassay on Elecsys and cobas eimmunoassay analyzers.</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Two</td><td rowspan=1 colspan=1>Two</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized, human serum</td><td rowspan=1 colspan=1>Lyophilized, equine serum</td></tr><tr><td rowspan=1 colspan=1>Analyte Concentration</td><td rowspan=1 colspan=1>Troponin I: 0.4 ng/mL and 30ng/mL</td><td rowspan=1 colspan=1>proBNP: 16.6 pmol/L and 320pmol/L</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened:Store at 2 - 8°C until expirationdate.Reconstituted:2-8°C: 4 days-20°C: 3 months (freeze onlyonceOn the Elecsys andMODULAR Analytics E170analyzers: use only once</td><td rowspan=1 colspan=1>Unopened:Store at 2 - 8°C until expirationdate.Reconstituted:2-8°C: 2 weeks-20°C: 3 months (freeze onlyonce)On Elecsys 1010/2010 andcobas e411 analyzers at 20 25°C: up to 5 hoursOn MODULAR ANALYTICSE170 and cobas e601analyzers: use only once</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Dissolve contents of one bottle byadding exactly 1.0 mL of distilledwater and allow to stand closed for60 minutes to reconstitute. Mixcarefully, avoiding the formation offoam.</td><td rowspan=1 colspan=1>Dissolve contents of one bottle byadding exactly 1.0 mL of distilledwater and allow to stand closed for15 minutes to reconstitute. Mixcarefully, avoiding the formation offoam.</td></tr></table>

The following table compares the Elecsys Troponin I STAT CalSet with the predicate device (K072437).

Device Comparison - STAT CalSet   

<table><tr><td rowspan=1 colspan=3>alSet Comparison</td></tr><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecsys Troponin I STAT CalSet</td><td rowspan=1 colspan=1>Elecsys proBNP I CalSet(K072437) Predicate</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The Elecsys Troponin 1 STATCalSet is used for calibrating thequantitative Elecsys Troponin ISTAT assay on the Elecsysanalyzers.</td><td rowspan=1 colspan=1>Used for calibrating thequantitative Elecsys proBNP Iassay on Elecsys and cobas eimmunoassay analyzers.</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Two</td><td rowspan=1 colspan=1>Two</td></tr><tr><td rowspan=1 colspan=1>Analyte Concentration</td><td rowspan=1 colspan=1>Troponin I: 0.4 ng/mL and 30ng/mL</td><td rowspan=1 colspan=1>CK-MB: approx. 5 and 50 ng/mlDigitoxin: approx 17 and 38ng/mL (not for use in U.S.)Digoxin: approx. 1.2 and 3 ng/mlMyoglobin: approx. 80 and 1000ng/mlNT-proBNP: approx. 0.15 and 5ng/ml</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized, human serum</td><td rowspan=1 colspan=1>Lyophilized, equine serum</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened:Store at 2 - 8°C until expirationdate.Reconstituted:2-8°C: 4 days• -20°C: 3 months (freeze onlyonce)On Elecsys analyzers: up to 5hours</td><td rowspan=1 colspan=1>Unopened:Store at 2 - 8°C until expirationdate.Reconstituted:2-8°C: 2 weeks-20°C: 3 months (freeze onlyonceOn Elecsys 1010/2010 andcobas e411 analyzers at 20 25°C: up to 5 hoursOn MODULAR ANALYTICSE170 and cobas e601analyzers: use only once</td></tr></table>

Device Comparison - STAT CalSet

The following table compares the Elecsys Troponin I STAT CalSet with the predicate device (K072437).

<table><tr><td rowspan=1 colspan=3>CalSet Comparison, continued</td></tr><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecsys Troponin I STAT CalSet</td><td rowspan=1 colspan=1>Elecsys proBNP Ⅱ CalSet(K072437) Predicate</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Dissolve contents of one bottle byadding exactly 1.0 mL of distilledwater and allow to stand closed for60 minutes to reconstitute. Mixcarefully, avoiding the formation offoam.</td><td rowspan=1 colspan=1>Dissolve contents of one bottle byadding exactly 1.0 mL of distilledwater and allow to stand closed for15 minutes to reconstitute. Mixcarefully, avoiding the formation offoam.</td></tr></table>

Roche Diagnostics Centralized Diagnostics c/o Dr. Jane Phillips Regulatory Affairs Principal 9115 Hague Road Indianapolis, IN 46250

Re: k082699 Trade Name: Roche Elecsys $\textsuperscript { \textregistered }$ Troponin I Immunoassay, Roche Elecsys® Troponin I STAT Immunoassay, Roche Elecsys $( \bigoplus$ PreciControl Troponin, Roche Elecsys $\textsuperscript { \textregistered }$ Troponin I CalSet, Roche Elecsys $^ \mathrm { \textregistered }$ Troponin I STAT CalSet Regulation Number: 21 CFR $\ S 8 6 2 . 1 2 1 5$ EY Regulation Name: Creatine phosphokinase/creatine kinase or isoenzymes test Regulatory Class: Class II Product Codes: MMI, JJY, JIT Dated: June 17, 2009 Received: June 18, 2009

Dear Dr. Phillips:

We have reviewed your Section $5 1 0 ( \mathrm { k } )$ premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Als0, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postniarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or ( 301 ) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

GC.H

Courtney C. Harper, Ph.D.   
Acting Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use - Elecsys Troponin I Immunoassay

510(k) Number: 082699

Device Name: Elecsys Troponin I Immunoassay

Indication for Use: Immunoassay for the in vitro quantitative determination of cardiac troponin I in human serum and plasma. The Elecsys Troponin I assay is intended to aid in the diagnosis of myocardial infarction.

The electrochemiluminescence immunoassay "ECLIA" is intended for use on the Elecsys and MODULAR Analytics E170 immunoassay analyzers.

# Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)

![](images/738d5b6103e799a7c8db152ffb35f3b4051bd711326b433df5fdb5134b05a946.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use - Elecsys Troponin I STAT Immunoassay

510(k) Number: 082699

Device Name: Elecsys Troponin I STAT Immunoassay

Indication for Use: Immunoassay for the in vitro quantitative determination of cardiac troponin I in human serum and plasma. The Elecsys Troponin I STAT assay is intended to aid in the diagnosis of myocardial infarction.

The electrochemiluminescence immunoassay "ECLIA" is intended for use on the Elecsys analyzers.

# Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)

![](images/ad32d49253cff8df23a1aaf66389618fb95f31f4e387c7acb93a7f080494e42e.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use - Elecsys PreciControl Troponin

510(k) Number: 082699

Device Name: Elecsys PreciControl Troponin

Elecsys PreciControl Troponin is used for quality control of the Elecsys Troponin I and Elecsys Troponin I STAT immunoassays on the Elecsys and MODULAR Analytics E170 Analyzers.

# Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)

![](images/28b6129afe375270859f6563d72b8bad2f433ae796b397353331be2833721899.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) K082699

Page 3f5

# Indications for Use - Elecsys Troponin I CalSet

510(k) Number: 082699

Device Name: Elecsys Troponin I CalSet

Elecsys Troponin I CalSet is used for calibrating the quantitative Elecsys Troponin I assay on the Elecsys and MODULAR Analytics E170 analyzers.

# Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)

![](images/97fdf29c3382dd21b911c65e83e98d2bf73a06e1772863377939238cbdfb9a71.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use - Elecsys Troponin I STAT CalSet

510(k) Number: 082699

Device Name: Elecsys Troponin I STAT CalSet

Elecys Troponin I STAT CalSet is used for calibrating the uantitative Elecsys Troponi I STAT assay on the Elecsys analyzers.

# C O InDDvval  Se

![](images/16082b8463b373612af6384d0344f2a543421461f10eb891e595b27952a8dbe9.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety